Your browser is no longer supported. Please, upgrade your browser.
UTHR United Therapeutics Corporation monthly Stock Chart
UTHR [NASD]
United Therapeutics Corporation
Index- P/E11.23 EPS (ttm)9.75 Insider Own0.20% Shs Outstand44.10M Perf Week-2.94%
Market Cap4.84B Forward P/E10.25 EPS next Y10.68 Insider Trans-81.93% Shs Float43.63M Perf Month-5.60%
Income429.80M PEG- EPS next Q2.55 Inst Own97.53% Short Float4.43% Perf Quarter-5.92%
Sales1.43B P/S3.38 EPS this Y-117.90% Inst Trans3.98% Short Ratio3.83 Perf Half Y5.07%
Book/sh70.15 P/B1.56 EPS next Y-1.58% ROA10.60% Target Price144.44 Perf Year37.66%
Cash/sh35.33 P/C3.10 EPS next 5Y-6.60% ROE14.90% 52W Range75.58 - 127.79 Perf YTD24.28%
Dividend- P/FCF8.10 EPS past 5Y-18.90% ROI-3.60% 52W High-14.34% Beta0.78
Dividend %- Quick Ratio7.10 Sales past 5Y2.40% Gross Margin92.20% 52W Low44.84% ATR2.88
Employees920 Current Ratio7.40 Sales Q/Q-3.10% Oper. Margin38.10% RSI (14)40.21 Volatility1.98% 2.65%
OptionableYes Debt/Eq0.26 EPS Q/Q-48.30% Profit Margin30.00% Rel Volume0.34 Prev Close109.38
ShortableYes LT Debt/Eq0.26 EarningsJul 29 BMO Payout0.00% Avg Volume505.32K Price109.47
Recom2.20 SMA20-3.13% SMA50-6.26% SMA2006.57% Volume169,870 Change0.08%
Jun-25-20Reiterated H.C. Wainwright Neutral $85 → $125
Mar-10-20Upgrade Jefferies Hold → Buy $123
Feb-27-20Upgrade Cowen Market Perform → Outperform $119 → $145
Jan-31-20Upgrade JP Morgan Neutral → Overweight $120
Dec-03-19Initiated BofA/Merrill Underperform
Aug-01-19Upgrade Ladenburg Thalmann Neutral → Buy $103 → $106
Aug-01-19Upgrade Jefferies Underperform → Hold $90
Jul-01-19Upgrade Credit Suisse Neutral → Outperform $98 → $101
May-17-19Upgrade UBS Sell → Neutral $115 → $94
May-09-19Upgrade Credit Suisse Underperform → Neutral $98
Oct-12-18Upgrade Standpoint Research Hold → Buy
Aug-08-18Downgrade Credit Suisse Neutral → Underperform
Apr-03-18Upgrade Credit Suisse Underperform → Neutral
Feb-22-18Reiterated Barclays Underweight $115 → $105
Jan-18-18Resumed Credit Suisse Underperform $118
Dec-27-17Reiterated Wedbush Outperform $213 → $232
Apr-27-17Reiterated Wedbush Outperform $229 → $213
Mar-30-17Initiated UBS Sell $112
Mar-16-17Initiated Credit Suisse Underperform
Mar-06-17Downgrade Jefferies Hold → Underperform
Aug-05-20 06:00AM  
Jul-30-20 07:32PM  
11:41AM  
Jul-29-20 08:02PM  
08:47AM  
07:30AM  
07:23AM  
Jul-23-20 06:00AM  
Jul-22-20 12:32PM  
06:00AM  
Jul-15-20 01:15PM  
Jul-13-20 04:18PM  
Jul-07-20 11:14AM  
Jul-06-20 10:35AM  
Jun-30-20 05:18PM  
Jun-17-20 06:00AM  
Jun-16-20 08:37PM  
Jun-09-20 02:56PM  
Jun-08-20 12:29PM  
Jun-05-20 11:06AM  
06:00AM  
May-29-20 11:31AM  
May-28-20 11:34AM  
May-26-20 06:00AM  
May-14-20 01:46PM  
May-06-20 06:00AM  
May-04-20 02:29PM  
May-01-20 12:00PM  
Apr-30-20 08:00AM  
Apr-29-20 06:31PM  
07:30AM  
06:00AM  
Apr-23-20 06:00AM  
Apr-09-20 11:00AM  
Apr-01-20 05:50PM  
Mar-27-20 02:53PM  
11:30AM  
Mar-16-20 11:30AM  
Mar-15-20 11:28PM  
Feb-28-20 11:30AM  
06:43AM  
Feb-27-20 10:44AM  
10:40AM  
09:41AM  
Feb-26-20 09:03AM  
07:30AM  
Feb-25-20 08:17AM  
06:00AM  
Feb-24-20 01:56PM  
06:16AM  
06:00AM  
Feb-21-20 02:25PM  
Feb-19-20 12:31PM  
11:13AM  
06:00AM  
Feb-18-20 09:51AM  
Feb-14-20 10:36AM  
Feb-05-20 03:01PM  
02:39PM  
11:15AM  
07:43AM  
Feb-04-20 12:10PM  
Feb-03-20 08:42AM  
06:00AM  
Jan-17-20 08:16AM  
Jan-06-20 06:00AM  
Jan-03-20 09:01AM  
Dec-27-19 03:40PM  
Dec-17-19 02:07PM  
Dec-06-19 03:07PM  
Dec-03-19 04:44PM  
02:43PM  
Nov-14-19 07:00AM  
Nov-08-19 08:56AM  
Nov-04-19 11:38AM  
Oct-31-19 11:45AM  
06:50AM  
Oct-30-19 10:54AM  
07:30AM  
06:00AM  
Oct-29-19 10:40AM  
10:10AM  
08:44AM  
Oct-25-19 11:28AM  
Oct-23-19 10:33AM  
06:00AM  
Oct-21-19 06:00AM  
Oct-18-19 11:12AM  
Oct-14-19 09:15AM  
Oct-02-19 05:00AM  
Sep-18-19 05:58AM  
Sep-12-19 11:25AM  
07:00AM  
Sep-11-19 06:00AM  
Aug-23-19 12:00PM  
Aug-19-19 04:35PM  
Aug-16-19 09:24AM  
Aug-14-19 07:00AM  
Aug-10-19 08:32AM  
Aug-09-19 09:25AM  
United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening diseases primarily in the United States and internationally. The company's commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhace the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients; and Unituxin, a monoclonal antibody for treating neuroblastoma. It also engages in developing OreniPro, RemoPro, Treprostinil Technosphere, Trevyent, Ralinepag, and Aurora-GT to treat PAH; LNG01 to treat IPF; Unexisome to treat BPD; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, biomechanical lungs, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. The company has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder, and Dreamboat and Cricket devices; Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH; and Samumed LLC to develop LNG01. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PATUSKY CHRISTOPHERDirectorAug 05Option Exercise54.775,000273,8507,300Aug 06 06:13 PM
ROTHBLATT MARTINE AChairman & CEOJul 09Option Exercise63.224,834305,6054,974Jul 09 07:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 09Sale117.044,834565,782140Jul 09 07:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 08Option Exercise63.2210,000632,20010,140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 08Sale117.9110,0001,179,051140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 07Option Exercise63.2210,000632,20010,140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 07Sale119.3110,0001,193,095140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 06Option Exercise63.2210,000632,20010,140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 06Sale119.6010,0001,196,030140Jul 08 07:54 PM
CAUSEY CHRISTOPHERDirectorJul 02Option Exercise63.9075047,9251,575Jul 06 08:04 AM
ROTHBLATT MARTINE AChairman & CEOJul 02Option Exercise63.2210,000632,20010,140Jul 02 04:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 02Sale120.7310,0001,207,257140Jul 02 04:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 01Option Exercise63.2210,000632,20010,140Jul 02 04:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 01Sale121.3910,0001,213,877140Jul 02 04:58 PM
ROTHBLATT MARTINE AChairman & CEOJun 30Option Exercise63.2210,000632,20010,140Jul 01 07:14 PM
ROTHBLATT MARTINE AChairman & CEOJun 30Sale120.3610,0001,203,586140Jul 01 07:14 PM
ROTHBLATT MARTINE AChairman & CEOJun 29Option Exercise63.2210,000632,20010,140Jul 01 07:14 PM
ROTHBLATT MARTINE AChairman & CEOJun 29Sale120.0110,0001,200,103140Jul 01 07:14 PM
DWEK RAYMONDDirectorJun 29Sale116.814,600537,3230Jun 30 01:56 PM
PATUSKY CHRISTOPHERDirectorJun 26Option Exercise0.002,30002,300Jun 30 02:03 PM
SULLIVAN LOUIS WDirectorJun 26Option Exercise0.002,30009,420Jun 30 02:03 PM
Olian Judy D.DirectorJun 26Option Exercise0.002,30005,790Jun 30 02:02 PM
Mesa NildaDirectorJun 26Option Exercise0.002,30004,960Jun 30 01:59 PM
KURZWEIL RAYDirectorJun 26Option Exercise0.002,30007,540Jun 30 01:59 PM
Giltner RichardDirectorJun 26Option Exercise0.004,60008,350Jun 30 01:57 PM
DWEK RAYMONDDirectorJun 26Option Exercise0.004,60004,600Jun 30 01:56 PM
ROTHBLATT MARTINE AChairman & CEOJun 26Option Exercise63.2210,000632,20010,140Jun 26 05:39 PM
ROTHBLATT MARTINE AChairman & CEOJun 26Sale121.0010,0001,210,047140Jun 26 05:39 PM
ROTHBLATT MARTINE AChairman & CEOJun 25Option Exercise63.2210,000632,20010,140Jun 26 05:39 PM
ROTHBLATT MARTINE AChairman & CEOJun 25Sale125.0610,0001,250,607140Jun 26 05:39 PM
ROTHBLATT MARTINE AChairman & CEOJun 24Option Exercise63.2210,000632,20010,140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 24Sale120.3410,0001,203,404140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 23Option Exercise63.2210,000632,20010,140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 23Sale120.4610,0001,204,650140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 22Option Exercise63.2210,000632,20010,140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 22Sale117.8110,0001,178,100140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 19Option Exercise63.2210,000632,20010,140Jun 19 05:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 19Sale116.7610,0001,167,568140Jun 19 05:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 18Option Exercise63.2210,000632,20010,140Jun 19 05:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 18Sale115.9510,0001,159,453140Jun 19 05:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 17Option Exercise63.2210,000632,20010,140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 17Sale117.8210,0001,178,173140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 16Option Exercise63.2210,000632,20010,140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 16Sale114.3110,0001,143,148140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 15Option Exercise63.2210,000632,20010,140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 15Sale113.8710,0001,138,662140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 12Option Exercise63.2210,000632,20010,140Jun 12 05:02 PM
ROTHBLATT MARTINE AChairman & CEOJun 12Sale115.6910,0001,156,897140Jun 12 05:02 PM
ROTHBLATT MARTINE AChairman & CEOJun 11Option Exercise63.2210,000632,20010,140Jun 12 05:02 PM
ROTHBLATT MARTINE AChairman & CEOJun 11Sale118.0310,0001,180,302140Jun 12 05:02 PM
ROTHBLATT MARTINE AChairman & CEOJun 10Option Exercise63.2210,000632,20010,140Jun 10 04:49 PM
ROTHBLATT MARTINE AChairman & CEOJun 10Sale124.7810,0001,247,834140Jun 10 04:49 PM
ROTHBLATT MARTINE AChairman & CEOJun 09Option Exercise63.2210,000632,20010,140Jun 10 04:49 PM
Thompson Tommy GDirectorJun 09Sale126.794,210533,8069,790Jun 10 04:50 PM
ROTHBLATT MARTINE AChairman & CEOJun 09Sale125.6910,0001,256,950140Jun 10 04:49 PM
ROTHBLATT MARTINE AChairman & CEOJun 08Option Exercise63.2210,000632,20010,140Jun 10 04:49 PM
ROTHBLATT MARTINE AChairman & CEOJun 08Sale124.7510,0001,247,525140Jun 10 04:49 PM
Olian Judy D.DirectorJun 08Sale124.964,510563,5913,490Jun 08 06:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 05Option Exercise63.2210,000632,20010,140Jun 05 06:53 PM
ROTHBLATT MARTINE AChairman & CEOJun 05Sale123.5910,0001,235,862140Jun 05 06:53 PM
ROTHBLATT MARTINE AChairman & CEOJun 04Option Exercise63.2210,000632,20010,140Jun 05 06:53 PM
CAUSEY CHRISTOPHERDirectorJun 04Option Exercise63.9075047,9251,575Jun 05 06:18 PM
ROTHBLATT MARTINE AChairman & CEOJun 04Sale123.5510,0001,235,493140Jun 05 06:53 PM
ROTHBLATT MARTINE AChairman & CEOJun 03Option Exercise63.2210,000632,20010,140Jun 03 06:28 PM
ROTHBLATT MARTINE AChairman & CEOJun 03Sale124.5210,0001,245,215140Jun 03 06:28 PM
ROTHBLATT MARTINE AChairman & CEOJun 02Option Exercise63.2210,000632,20010,140Jun 03 06:28 PM
ROTHBLATT MARTINE AChairman & CEOJun 02Sale121.7910,0001,217,916140Jun 03 06:28 PM
ROTHBLATT MARTINE AChairman & CEOJun 01Option Exercise63.2210,000632,20010,140Jun 03 06:28 PM
ROTHBLATT MARTINE AChairman & CEOJun 01Sale119.2810,0001,192,762140Jun 03 06:28 PM
ROTHBLATT MARTINE AChairman & CEOMay 29Option Exercise63.2210,000632,20010,140Jun 01 08:07 AM
ROTHBLATT MARTINE AChairman & CEOMay 29Sale115.9110,0001,159,091140Jun 01 08:07 AM
ROTHBLATT MARTINE AChairman & CEOMay 28Option Exercise63.2210,000632,20010,140Jun 01 08:07 AM
ROTHBLATT MARTINE AChairman & CEOMay 28Sale116.2810,0001,162,839140Jun 01 08:07 AM
ROTHBLATT MARTINE AChairman & CEOMay 27Option Exercise63.2210,000632,20010,140May 27 06:20 PM
ROTHBLATT MARTINE AChairman & CEOMay 27Sale115.9010,0001,159,025140May 27 06:20 PM
ROTHBLATT MARTINE AChairman & CEOMay 26Option Exercise63.2210,000632,20010,140May 27 06:20 PM
ROTHBLATT MARTINE AChairman & CEOMay 26Sale119.6510,0001,196,475140May 27 06:20 PM
ROTHBLATT MARTINE AChairman & CEOMay 22Option Exercise63.2210,000632,20010,140May 22 05:04 PM
ROTHBLATT MARTINE AChairman & CEOMay 22Sale117.3010,0001,173,015140May 22 05:04 PM
ROTHBLATT MARTINE AChairman & CEOMay 21Option Exercise63.2210,000632,20010,140May 22 05:04 PM
ROTHBLATT MARTINE AChairman & CEOMay 21Sale117.8210,0001,178,240140May 22 05:04 PM
ROTHBLATT MARTINE AChairman & CEOMay 20Option Exercise63.2210,000632,20010,140May 20 05:23 PM
ROTHBLATT MARTINE AChairman & CEOMay 20Sale120.0810,0001,200,778140May 20 05:23 PM
ROTHBLATT MARTINE AChairman & CEOMay 19Option Exercise63.2210,000632,20010,140May 20 05:23 PM
ROTHBLATT MARTINE AChairman & CEOMay 19Sale121.3010,0001,213,031140May 20 05:23 PM
ROTHBLATT MARTINE AChairman & CEOMay 18Option Exercise63.2210,000632,20010,140May 20 05:23 PM
ROTHBLATT MARTINE AChairman & CEOMay 18Sale118.4510,0001,184,471140May 20 05:23 PM
CAUSEY CHRISTOPHERDirectorMay 15Option Exercise63.903,750239,6254,575May 18 04:40 PM
Thompson Tommy GDirectorMay 05Sale112.563,100348,92114,000May 05 07:12 PM
DWEK RAYMONDDirectorMay 04Option Exercise51.775,000258,8505,000May 05 04:34 PM
Giltner RichardDirectorApr 20Option Exercise51.775,000258,8508,750Apr 21 04:31 PM
Giltner RichardDirectorApr 20Sale107.005,000535,0003,750Apr 21 04:31 PM
Giltner RichardDirectorApr 14Option Exercise51.775,000258,8508,750Apr 15 04:32 PM
Giltner RichardDirectorApr 14Sale99.005,000495,0003,750Apr 15 04:32 PM
Giltner RichardDirectorMar 26Option Exercise51.775,000258,8508,750Mar 27 04:34 PM
Giltner RichardDirectorMar 26Sale91.755,000458,7503,750Mar 27 04:34 PM
SULLIVAN LOUIS WDirectorMar 25Option Exercise48.1115,000721,65022,120Mar 27 04:33 PM
SULLIVAN LOUIS WDirectorMar 23Option Exercise54.776,000328,62013,120Mar 24 04:32 PM
PATUSKY CHRISTOPHERDirectorMar 17Option Exercise54.775,000273,8505,000Mar 18 04:30 PM
Thompson Tommy GDirectorMar 02Option Exercise51.778,500440,04530,440Mar 03 04:02 PM